Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.